Amphastar Pharmaceuticals AMPH Share Buybacks
Share Buybacks at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's share buybacks.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's share buybacks?
- Amphastar Pharmaceuticals (AMPH) reported share buybacks of $29.49M in Q1 2026.
- How has Amphastar Pharmaceuticals's share buybacks changed year-over-year?
- Amphastar Pharmaceuticals's share buybacks increased by 168.1% year-over-year, from $11M to $29.49M.
- What is the long-term trend for Amphastar Pharmaceuticals's share buybacks?
- Over 3 years (2021 to 2025), Amphastar Pharmaceuticals's share buybacks has grown at a 37.8% compound annual growth rate (CAGR), from $28.87M to $75.59M.
- What does share buybacks mean?
- Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.